{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-007532","form_type":"8-K","ticker":"DRMA","cik":"0001853816","company_name":"Dermata Therapeutics, Inc.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.871637+00:00","generated_at":"2026-06-01T05:41:40.539918+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Dermata Therapeutics enters ATM equity facility for up to ~$1.16M","bullets":["ATM Agreement with H.C. Wainwright for at-the-market issuance of common stock up to $1,157,761 aggregate market value.","Commission rate 3.0% of gross sales price; expense reimbursement up to $70,000 plus periodic due diligence fees.","Company has no obligation to sell; sales at prevailing market prices on Nasdaq under effective shelf registration statement.","Offering terminates upon sale of all shares or earlier termination by either party."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-007532","json":"https://secwatch.observer/filing/0001654954-24-007532.json","markdown":"https://secwatch.observer/filing/0001654954-24-007532.md","text":"https://secwatch.observer/filing/0001654954-24-007532.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1853816/000165495424007532/0001654954-24-007532-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1853816/000165495424007532/drma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:41:40.539918+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}